Fundraising Fox
Schrodinger
NASDAQ: SDGRUnicorn · $3.6BNew York, US · Founded 1990 · Delaware corporation · 1,003 employees on LinkedIn · 4 known investors
Find your way into Schrodinger
Sign up to see every warm intro you have to Schrodinger
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Schrodinger team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Schrödinger develops a physics-based computational platform for discovering and optimizing molecules, used to accelerate drug discovery and materials design. The company also operates a therapeutics group that pursues drug development on validated targets and offers educational resources for the field.
Founders & leadership
Schrodinger was founded in 1990 by Richard A. Friesner.
Board
Investors · 4
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$129.8M disclosed across 2 rounds · 2015–2018
▶$107.8MraisedMay 2019 · 13 investors · BiotechnologyRule 506(b)
- Joel LebowitzExecutive Officer
- Rosana Kapeller-LiebermannDirector
- Cony D'CruzExecutive Officer
- Yvonne TranExecutive Officer
- Michael LyntonDirector
- Timothy WrightDirector
- Richard FriesnerDirector
- Ramy FaridExecutive Officer, Director
- Offering amount
- $115M
- Amount sold
- $107.8M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22MraisedJun 2015 · 2 investors · BiotechnologyRule 506(b)
- Timothy WrightDirector
- Murco RingnaldaExecutive Officer
- Ramy FaridExecutive Officer, Director
- Charles ArdaiDirector
- Joshua DistlerDirector
- Richard FriesnerDirector
- Offering amount
- $22M
- Amount sold
- $22M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 1
Companies working in the same space as Schrodinger.
Frequently asked questions
- What does Schrodinger do?
- Schrödinger develops a physics-based computational platform for discovering and optimizing molecules, used to accelerate drug discovery and materials design. The company also operates a therapeutics group that pursues drug development on validated targets and offers educational resources for the field.
- Who founded Schrodinger?
- Schrodinger was founded by Richard A. Friesner in 1990.
- Who are Schrodinger's investors?
- Schrodinger's investors include Qiming Venture Partners, Bill & Melinda Gates Foundation Trust, GV (Google Ventures), Sixty Degree Capital.
- How much funding has Schrodinger raised?
- Schrodinger has disclosed $129.8M raised across 2 rounds.
- Where is Schrodinger headquartered?
- Schrodinger is headquartered in New York, US.